Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Martin Shkreli Is Shorting This ‘Strong Buy’ Penny Stock. How Should You Play Shares Here?

aTyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short position against the biotherapeutics firm. 

According to Shkreli, investors should pull out of aTyr shares at current levels as they could crash as much as 80% within the next six weeks.  

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.